111 related articles for article (PubMed ID: 6187447)
21. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
Mitchell BS; Edwards NL
J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
[TBL] [Abstract][Full Text] [Related]
22. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
Matsumoto M; Weckbecker G; Cory JG
Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
[TBL] [Abstract][Full Text] [Related]
23. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
Matsumoto SS; Yu J; Yu AL
J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
[TBL] [Abstract][Full Text] [Related]
24. Deoxyadenosine induced G1 phase arrest in leukemic T cells.
Fox RM; Tripp EH; Taylor IW
Adv Exp Med Biol; 1984; 165 Pt B():333-8. PubMed ID: 6609539
[No Abstract] [Full Text] [Related]
25. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
[TBL] [Abstract][Full Text] [Related]
26. Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.
Callard RE; Ewing TM; Fox RM
Clin Exp Immunol; 1984 Oct; 58(1):136-44. PubMed ID: 6236916
[TBL] [Abstract][Full Text] [Related]
27. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
Overgaard-Hansen K; Klenow H
J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
Szabados E; Duggleby RG; Christopherson RI
Int J Biochem Cell Biol; 1996 Dec; 28(12):1405-15. PubMed ID: 9022297
[TBL] [Abstract][Full Text] [Related]
29. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
Veit BC; Fishman M; Look T
J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
[TBL] [Abstract][Full Text] [Related]
30. [Nuclear and cytoplasmic poly A-containing RNA in normal and leukemic human leukocytes].
Blinov MN; Vladimirova AD; Luganova IS
Vopr Onkol; 1978; 24(10):23-7. PubMed ID: 716312
[TBL] [Abstract][Full Text] [Related]
31. S-adenosylhomocysteine hydrolase inhibition in deoxyadenosine-treated human T-lymphoblasts and resting peripheral blood lymphocytes.
Kefford RF; Helmer MA; Fox RM
Cancer Res; 1982 Sep; 42(9):3822-7. PubMed ID: 6980705
[No Abstract] [Full Text] [Related]
32. Metabolism of polyadenylated mRNA in growing human lymphocytes.
Berger SL; Birkenmeier CS
Biochim Biophys Acta; 1979 Mar; 562(1):80-91. PubMed ID: 312113
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency.
Waddell D; Ullman B
J Biol Chem; 1983 Apr; 258(7):4226-31. PubMed ID: 6339493
[TBL] [Abstract][Full Text] [Related]
34. [Polyadenylated RNA and poly-A segments in the splenic cells of mice with virus-induced Rauscher leukemia].
Smirnova IA; Nakonechnyĭ NV
Vopr Med Khim; 1983; 29(6):63-9. PubMed ID: 6199896
[TBL] [Abstract][Full Text] [Related]
35. Distinct effects of adenine and guanine starvation on DNA synthesis associated with different pool sizes of nucleotide precursors.
Duan DS; Sadée W
Cancer Res; 1987 Aug; 47(15):4047-51. PubMed ID: 3496954
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo.
Mitchell BS; Koller CA; Heyn R
Blood; 1980 Sep; 56(3):556-9. PubMed ID: 6967747
[TBL] [Abstract][Full Text] [Related]
37. Interference of deoxyadenosine with transmembrane signaling events in human T lymphocytes.
Scharenberg JG; Rijkers GT; Akkerman JW; Staal GE; Zegers BJ
Int J Immunopharmacol; 1990; 12(1):113-20. PubMed ID: 2303314
[TBL] [Abstract][Full Text] [Related]
38. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
[TBL] [Abstract][Full Text] [Related]
39. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
Wortmann RL; Mitchell BS; Edwards NL; Fox IH
Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
[TBL] [Abstract][Full Text] [Related]
40. Differential incorporation of 2'-deoxyadenosine into human peripheral lymphocytes.
Burgess FW; Stoeckler JD; Parks RE
Biochem Pharmacol; 1985 Sep; 34(18):3353-60. PubMed ID: 3929793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
